BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36103261)

  • 1. Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years.
    Plym A; Zhang Y; Stopsack KH; Jee YH; Wiklund F; Kibel AS; Kraft P; Giovannucci E; Penney KL; Mucci LA
    Clin Cancer Res; 2022 Nov; 28(22):4926-4933. PubMed ID: 36103261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
    Dite GS; Spaeth E; Murphy NM; Allman R
    Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history.
    Hassanin E; May P; Aldisi R; Spier I; Forstner AJ; Nöthen MM; Aretz S; Krawitz P; Bobbili DR; Maj C
    Genet Med; 2022 Mar; 24(3):576-585. PubMed ID: 34906469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer.
    Plym A; Zhang Y; Stopsack KH; Delcoigne B; Wiklund F; Haiman C; Kenfield SA; Kibel AS; Giovannucci E; Penney KL; Mucci LA
    Eur Urol; 2023 Apr; 83(4):343-351. PubMed ID: 35637041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a prostate cancer polygenic risk score.
    Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
    Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.
    Amin Al Olama A; Benlloch S; Antoniou AC; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Muir K; Schleutker J; Henderson BE; Haiman CA; Schumacher FR; Pashayan N; Pharoah PD; Ostrander EA; Stanford JL; Batra J; Clements JA; Chambers SK; Weischer M; Nordestgaard BG; Ingles SA; Sorensen KD; Orntoft TF; Park JY; Cybulski C; Maier C; Doerk T; Dickinson JL; Cannon-Albright L; Brenner H; Rebbeck TR; Zeigler-Johnson C; Habuchi T; Thibodeau SN; Cooney KA; Chappuis PO; Hutter P; Kaneva RP; Foulkes WD; Zeegers MP; Lu YJ; Zhang HW; Stephenson R; Cox A; Southey MC; Spurdle AB; FitzGerald L; Leongamornlert D; Saunders E; Tymrakiewicz M; Guy M; Dadaev T; Little SJ; Govindasami K; Sawyer E; Wilkinson R; Herkommer K; Hopper JL; Lophatonanon A; Rinckleb AE; Kote-Jarai Z; Eeles RA; Easton DF; ; ;
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1121-9. PubMed ID: 25837820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
    Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Elife; 2022 Jul; 11():. PubMed ID: 35801699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of breast cancer risk based on profiling with common genetic variants.
    Mavaddat N; Pharoah PD; Michailidou K; Tyrer J; Brook MN; Bolla MK; Wang Q; Dennis J; Dunning AM; Shah M; Luben R; Brown J; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Czene K; Darabi H; Eriksson M; Peto J; Dos-Santos-Silva I; Dudbridge F; Johnson N; Schmidt MK; Broeks A; Verhoef S; Rutgers EJ; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Figueroa J; Chanock SJ; Brinton L; Lissowska J; Couch FJ; Olson JE; Vachon C; Pankratz VS; Lambrechts D; Wildiers H; Van Ongeval C; van Limbergen E; Kristensen V; Grenaker Alnæs G; Nord S; Borresen-Dale AL; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Trentham-Dietz A; Newcomb P; Titus L; Egan KM; Hunter DJ; Lindstrom S; Tamimi RM; Kraft P; Rahman N; Turnbull C; Renwick A; Seal S; Li J; Liu J; Humphreys K; Benitez J; Pilar Zamora M; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Bogdanova NV; Antonenkova NN; Dörk T; Anton-Culver H; Neuhausen SL; Ziogas A; Bernstein L; Devilee P; Tollenaar RA; Seynaeve C; van Asperen CJ; Cox A; Cross SS; Reed MW; Khusnutdinova E; Bermisheva M; Prokofyeva D; Takhirova Z; Meindl A; Schmutzler RK; Sutter C; Yang R; Schürmann P; Bremer M; Christiansen H; Park-Simon TW; Hillemanns P; Guénel P; Truong T; Menegaux F; Sanchez M; Radice P; Peterlongo P; Manoukian S; Pensotti V; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Brauch H; Brüning T; Ko YD; Sigurdson AJ; Doody MM; Hamann U; Torres D; Ulmer HU; Försti A; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Andrulis IL; Knight JA; Glendon G; Marie Mulligan A; Chenevix-Trench G; Balleine R; Giles GG; Milne RL; McLean C; Lindblom A; Margolin S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Eilber U; Wang-Gohrke S; Hooning MJ; Hollestelle A; van den Ouweland AM; Koppert LB; Carpenter J; Clarke C; Scott R; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Brenner H; Arndt V; Stegmaier C; Karina Dieffenbach A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Offit K; Vijai J; Robson M; Rau-Murthy R; Dwek M; Swann R; Annie Perkins K; Goldberg MS; Labrèche F; Dumont M; Eccles DM; Tapper WJ; Rafiq S; John EM; Whittemore AS; Slager S; Yannoukakos D; Toland AE; Yao S; Zheng W; Halverson SL; González-Neira A; Pita G; Rosario Alonso M; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; Simard J; Hall P; Easton DF; Garcia-Closas M
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy dietary patterns and risk of prostate cancer in men at high genetic risk.
    Zhang Y; Stopsack KH; Song M; Mucci LA; Liu B; Penney KL; Tabung FK; Giovannucci E; Plym A
    Int J Cancer; 2024 Jul; 155(1):71-80. PubMed ID: 38429859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer risk prediction using a polygenic risk score.
    Sipeky C; Talala KM; Tammela TLJ; Taari K; Auvinen A; Schleutker J
    Sci Rep; 2020 Oct; 10(1):17075. PubMed ID: 33051487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
    Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
    Plym A; Penney KL; Kalia S; Kraft P; Conti DV; Haiman C; Mucci LA; Kibel AS
    J Natl Cancer Inst; 2022 May; 114(5):771-774. PubMed ID: 33792693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
    Ruan X; Huang D; Huang J; Tsu JH; Na R
    J Transl Med; 2023 Jul; 21(1):446. PubMed ID: 37415201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
    Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic and clinical risk factors: association with fatal prostate cancer in the Cohort of Swedish Men.
    Huynh-Le MP; Karunamuni R; Fan CC; Thompson WK; Muir K; Lophatananon A; Tye K; Wolk A; Håkansson N; Mills IG; Andreassen OA; Dale AM; Seibert TM;
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):845-851. PubMed ID: 33723363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
    Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M
    J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
    Lindström S; Schumacher FR; Cox D; Travis RC; Albanes D; Allen NE; Andriole G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Crawford ED; Diver WR; Gaziano JM; Giles GG; Giovannucci E; Gonzalez CA; Henderson B; Hunter DJ; Johansson M; Kolonel LN; Ma J; Le Marchand L; Pala V; Stampfer M; Stram DO; Thun MJ; Tjonneland A; Trichopoulos D; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Hayes RB; Severi G; Haiman CA; Chanock SJ; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):437-44. PubMed ID: 22237985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
    Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL;
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
    Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.